Hologic, Inc. logo
Hologic, Inc. (HOLX)
Compare

Hologic, Inc. (HOLX) EV/EBITDA Ratio: 17.28x

Is Hologic, Inc.’s EV/EBITDA ratio high or low?

Hologic, Inc.'s EV/EBITDA ratio of 17.28x is 39% above its 5-year average of 12.41x, near the high end of its 5-year range (6.17x–19.44x).

As of Thursday, June 11, 2026. 15.14% above its 12-month average of 15.01x.

HOLX EV/EBITDA Ratio Chart

HOLX EV/EBITDA Ratio
17.28x+54.84% 1Y
Zoom

HOLX Average EV/EBITDA Ratio Chart

HOLX Current vs Average EV/EBITDA Ratio Chart

HOLX EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

17.28x

EV/EBITDA RATIO AVG TTM

15.01x

EV/EBITDA RATIO AVG 3Y

15.35x

EV/EBITDA RATIO AVG 5Y

12.41x

EV/EBITDA RATIO AVG 10Y

19.98x

EV/EBITDA RATIO AVG 15Y

18.87x

EV/EBITDA RATIO AVG 20Y

19.58x

CURRENT VS TTM AVG

+15.14%

CURRENT VS 3Y AVG

+12.54%

CURRENT VS 5Y AVG

+39.24%

CURRENT VS 10Y AVG

-13.49%

CURRENT VS 15Y AVG

-8.42%

CURRENT VS 20Y AVG

-11.76%

HOLX Competitors' EV/EBITDA Ratio

NAMEMARKET CAPEV/EBITDA RATIOTTM3Y5Y
Hologic, Inc. (HOLX)$16.97B17.28x15.01x15.35x12.41x
Moderna, Inc. (MRNA)$18.71BN/A12.39x25.27x25.27x
Align Technology, Inc. (ALGN)$12.27B13.98x13.90x20.40x25.86x
BioNTech SE (BNTX)$22.39BN/A51.40x19.63x20.05x
Mettler-Toledo International Inc. (MTD)$22.82B20.23x23.55x23.87x26.49x
Waters Corporation (WAT)$23.21B37.79x21.59x21.24x21.45x
Baxter International Inc. (BAX)$10.49B24.37x20.31x19.09x19.10x
Charles River Laboratories International, Inc. (CRL)$8.94B14.86x19.01x15.54x17.40x
Bio-Rad Laboratories, Inc. (BIO)$7.92B254.89x59.27x93.59x48.31x
Veeva Systems Inc. (VEEV)$26.31B19.71x33.42x44.03x54.13x

EV/EBITDA vs. its own history

At 17.3, EV/EBITDA is in its normal range, sitting higher than 64% of its 20-year history.

20-year low

6.2

median

15.2

20-year high

80.3

cheaperricher

Hologic, Inc. EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Hologic, Inc. EV/EBITDA Ratio FAQ

What is the EV/EBITDA ratio for Hologic, Inc. (HOLX)?
The EV/EBITDA ratio for HOLX stock is 17.28x.
Is Hologic, Inc.'s EV/EBITDA ratio high or low?
Hologic, Inc.'s EV/EBITDA ratio of 17.28x is 39% above its 5-year average of 12.41x, near the high end of its 5-year range (6.17x–19.44x).
What is the TTM average EV/EBITDA ratio for Hologic, Inc. (HOLX)?
The TTM average EV/EBITDA ratio for HOLX stock is 15.01x.
What is the 3Y average EV/EBITDA ratio for Hologic, Inc. (HOLX)?
The 3Y average EV/EBITDA ratio for HOLX stock is 15.35x.
What is the 5Y average EV/EBITDA ratio for Hologic, Inc. (HOLX)?
The 5Y average EV/EBITDA ratio for HOLX stock is 12.41x.
What is the 10Y average EV/EBITDA ratio for Hologic, Inc. (HOLX)?
The 10Y average EV/EBITDA ratio for HOLX stock is 19.98x.
What is the 15Y average EV/EBITDA ratio for Hologic, Inc. (HOLX)?
The 15Y average EV/EBITDA ratio for HOLX stock is 18.87x.
What is the 20Y average EV/EBITDA ratio for Hologic, Inc. (HOLX)?
The 20Y average EV/EBITDA ratio for HOLX stock is 19.58x.

Hologic, Inc. EV/EBITDA Ratio History

DATEEV/EBITDA RATIO
2026-04-0717.28x
2026-04-0617.28x
2026-04-0217.20x
2026-04-0117.19x
2026-03-3117.19x
2026-03-3017.18x
2026-03-2717.21x
2026-03-2617.21x
2026-03-2517.17x
2026-03-2417.18x
2026-03-2317.20x
2026-03-2017.15x
2026-03-1917.13x
2026-03-1817.09x
2026-03-1717.07x
2026-03-1617.09x
2026-03-1317.08x
2026-03-1217.10x
2026-03-1117.15x
2026-03-1017.18x
2026-03-0917.19x
2026-03-0617.22x
2026-03-0517.22x
2026-03-0417.21x
2026-03-0317.16x
2026-03-0217.16x
2026-02-2717.14x
2026-02-2617.11x
2026-02-2517.13x
2026-02-2417.13x
2026-02-2317.15x
2026-02-2017.15x
2026-02-1917.09x
2026-02-1817.10x
2026-02-1717.09x
2026-02-1317.07x
2026-02-1217.04x
2026-02-1117.08x
2026-02-1017.09x
2026-02-0917.06x
2026-02-0617.01x
2026-02-0516.99x
2026-02-0416.96x
2026-02-0316.97x
2026-02-0217.00x
2026-01-3017.04x
2026-01-2917.05x
2026-01-2816.28x
2026-01-2716.30x
2026-01-2616.30x
2026-01-2316.27x
2026-01-2216.28x
2026-01-2116.29x
2026-01-2016.28x
2026-01-1616.25x
2026-01-1516.26x
2026-01-1416.29x
2026-01-1316.23x
2026-01-1216.23x
2026-01-0916.23x
2026-01-0816.23x
2026-01-0716.25x
2026-01-0616.24x
2026-01-0516.21x
2026-01-0216.17x
2025-12-3116.15x
2025-12-3016.16x
2025-12-2916.16x
2025-12-2616.15x
2025-12-2416.15x
2025-12-2316.23x
2025-12-2216.24x
2025-12-1916.25x
2025-12-1816.25x
2025-12-1716.24x
2025-12-1616.26x
2025-12-1516.30x
2025-12-1216.26x
2025-12-1116.22x
2025-12-1016.22x
2025-12-0916.24x
2025-12-0816.23x
2025-12-0516.25x
2025-12-0416.23x
2025-12-0316.26x
2025-12-0216.22x
2025-12-0116.23x
2025-11-2816.25x
2025-11-2616.22x
2025-11-2516.23x
2025-11-2416.21x
2025-11-2116.13x
2025-11-2016.08x
2025-11-1916.09x
2025-11-1816.07x
2025-11-1716.04x
2025-11-1416.05x
2025-11-1316.07x
2025-11-1216.13x
2025-11-1116.14x
2025-11-1016.08x
2025-11-0716.04x
2025-11-0616.05x
2025-11-0516.06x
2025-11-0416.04x
2025-11-0316.03x
2025-10-3116.00x
2025-10-3016.00x
2025-10-2916.01x
2025-10-2816.02x
2025-10-2716.01x
2025-10-2416.01x
2025-10-2315.99x
2025-10-2216.00x
2025-10-2116.01x
2025-10-2015.58x
2025-10-1715.16x
2025-10-1614.88x
2025-10-1514.57x
2025-10-1414.35x
2025-10-1314.26x
2025-10-1014.73x
2025-10-0914.90x
2025-10-0814.85x
2025-10-0714.72x
2025-10-0614.64x
2025-10-0314.82x
2025-10-0214.76x
2025-10-0114.58x
2025-09-3014.67x
2025-09-2914.60x
2025-09-2614.61x
2025-09-2514.32x
2025-09-2414.44x
2025-09-2314.70x
2025-09-2214.63x
2025-09-1914.43x
2025-09-1814.83x
2025-09-1714.82x
2025-09-1613.81x
2025-09-1513.91x
2025-09-1214.04x
2025-09-1114.44x
2025-09-1014.26x
2025-09-0914.51x
2025-09-0814.47x
2025-09-0514.52x
2025-09-0414.44x
2025-09-0314.41x
2025-09-0214.49x
2025-08-2914.59x
2025-08-2814.49x
2025-08-2714.51x
2025-08-2614.49x
2025-08-2514.60x
2025-08-2214.83x
2025-08-2114.60x
2025-08-2014.93x
2025-08-1914.74x
2025-08-1814.62x
2025-08-1514.74x
2025-08-1414.79x
2025-08-1314.98x
2025-08-1214.77x
2025-08-1114.77x
2025-08-0814.79x
2025-08-0714.76x
2025-08-0614.55x
2025-08-0514.74x
2025-08-0414.76x
2025-08-0114.60x
2025-07-3114.53x
2025-07-3014.32x
2025-07-2914.53x
2025-07-2814.46x
2025-07-2514.63x
2025-07-2414.54x
2025-07-2314.51x
2025-07-2214.39x
2025-07-2114.05x
2025-07-1814.11x
2025-07-1714.12x
2025-07-1614.09x
2025-07-1513.96x
2025-07-1414.24x
2025-07-1114.47x
2025-07-1014.70x
2025-07-0914.49x
2025-07-0814.30x
2025-07-0714.19x
2025-07-0314.27x
2025-07-0214.38x
2025-07-0114.39x
2025-06-3014.35x
2025-06-2714.32x
2025-06-2614.34x
2025-06-2514.17x
2025-06-2414.28x
2025-06-2314.20x
2025-06-2014.21x
2025-06-1814.11x
2025-06-1714.14x
2025-06-1614.36x
2025-06-1314.27x
2025-06-1214.36x
2025-06-1114.23x
2025-06-1014.35x
2025-06-0914.23x
2025-06-0614.18x
2025-06-0513.92x
2025-06-0413.82x
2025-06-0313.92x
2025-06-0213.71x
2025-05-3013.74x
2025-05-2913.89x
2025-05-2814.05x
2025-05-2713.74x
2025-05-2312.12x
2025-05-2212.16x
2025-05-2112.23x
2025-05-2012.57x
2025-05-1912.56x
2025-05-1612.64x
2025-05-1512.42x
2025-05-1412.34x
2025-05-1312.70x
2025-05-1213.05x
2025-05-0912.63x
2025-05-0812.51x
2025-05-0712.36x
2025-05-0611.88x
2025-05-0511.80x
2025-05-0212.10x
2025-05-0110.47x
2025-04-3010.63x
2025-04-2910.65x
2025-04-2810.61x
2025-04-2510.60x
2025-04-2410.64x
2025-04-2310.62x
2025-04-2210.63x
2025-04-2110.41x
2025-04-1710.52x
2025-04-1610.33x
2025-04-1510.57x
2025-04-1410.74x
2025-04-1110.57x
2025-04-1010.45x
2025-04-0910.82x
2025-04-0810.67x
2025-04-0711.16x
2025-04-0411.09x
2025-04-0311.23x
2025-04-0211.04x
2025-04-0111.18x
2025-03-3111.24x
2025-03-2811.17x
2025-03-2711.34x
2025-03-2611.19x
2025-03-2511.08x

Showing the most recent 260 of 4,531 data points. The chart above shows the full history.

About Hologic, Inc.

Hologic, Inc. is a medical technology company focused on designing, producing, and marketing a diverse range of diagnostic tests, medical imaging systems, and surgical solutions. Its core mission is to enhance women's health through proactive detection and effective treatment, serving patients in the United States, across Europe, the Asia-Pacific region, and various other international markets. The company operates through four distinct business units: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. Within its Diagnostics segment, Hologic provides Aptima molecular diagnostic assays for identifying infectious microorganisms, alongside Aptima viral load tests for conditions like HIV, Hepatitis C, and Hepatitis B. It also offers Aptima and Panther Fusion SARS-CoV-2 assays for detecting the virus, the ThinPrep System for cytology applications, and the Rapid Fetal Fibronectin Test to help clinicians assess the likelihood of premature birth. Furthermore, the company supplies various diagnostic tests for Group B Streptococcus. The Breast Health division delivers advanced imaging and analytical solutions, including 2D and 3D digital mammography systems with accompanying reading workstations. This segment also features minimally invasive breast biopsy guidance systems and devices, products for marking and localizing breast biopsy sites, specimen radiology tools, ultrasound solutions, connectivity options, and products supporting breast-conserving surgical procedures. For GYN Surgical needs, Hologic offers the NovaSure Endometrial Ablation System, designed to manage abnormal uterine bleeding, and the MyoSure Hysteroscopic Tissue Removal System for the excision of uterine fibroids, polyps, and other pathologies. Additionally, the Fluent Fluid Management System facilitates liquid distention during diagnostic and operative hysteroscopic interventions. The Skeletal Health segment includes the Horizon DXA, a dual-energy X-ray system, and the Fluoroscan Insight FD mini C-arm, which is utilized for minimally invasive orthopedic surgical procedures. Hologic distributes its comprehensive product portfolio through a combination of its dedicated direct sales and service teams, as well as via independent distributors and sales representatives. Established in 1985, Hologic, Inc. maintains its corporate headquarters in Marlborough, Massachusetts.

Marlborough, MA
7,063 employees
Healthcare / Medical - Instruments & Supplies
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Paul Malenchini